Arkolith/Insider Trading/TMDX/Form 4

Hernandez Gerardo

Chief Financial OfficerTransMedics Group, Inc. (TMDX) · full profile →Form 4 · filed Mar 4, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.1M
Net Open-Market Flow
-$1.1M
Transactions
7
5 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 4, 2026Option exercise(M)6K$69.84$413K21K
Mar 4, 2026Option exercise(M)1K$77.12$102K16K
Mar 4, 2026Sell(S)1K$147.21$195K15K
Mar 4, 2026Sell(S)6K$147.21$870K15K
Mar 2, 2026Sell(S)375$139.12$52K15K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 4, 2026Option exercise(M)1K—$04K
Mar 4, 2026Option exercise(M)6K—$013K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-092241) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML